Bao-zhu Yuan
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The DLC-1 tumor suppressor is involved in regulating immunomodulation of human mesenchymal stromal /stem cells through interacting with the Notch1 protein.
Journal: BMC cancer
Published: December 14, 2019
Human lung epithelial BEAS-2B cells exhibit characteristics of mesenchymal stem cells.
Journal: PloS one
Published: September 25, 2019
DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-β1 signaling.
Journal: Experimental cell research
Published: March 12, 2019
Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells.
Journal: Stem cells translational medicine
Published: June 01, 2017
RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA.
Journal: PloS one
Published: March 30, 2017
Establishing a Quality Control System for Stem Cell-Based Medicinal Products in China.
Journal: Tissue engineering. Part A
Published: December 05, 2014
The notch signaling regulates CD105 expression, osteogenic differentiation and immunomodulation of human umbilical cord mesenchymal stem cells.
Journal: PloS one
Published: October 06, 2014
The regulatory sciences for stem cell-based medicinal products.
Journal: Frontiers of medicine
Published: July 13, 2013
TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages.
Journal: BMC cancer
Published: August 28, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026